Related Experiment Video
Updated: Apr 17, 2026

09:52
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
14.1K
Radiotherapy for cutaneous melanoma: current and future applications
Peter Gorayski1, Bryan Burmeister, Matthew Foote
1Department of Radiation Oncology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Future Oncology (London, England)
|February 13, 2015
Summary
Radiation therapy (RT) for cutaneous malignant melanoma is evolving. While historically limited by radioresistance, RT shows promise in high-risk nodal disease, palliative care, and oligometastatic scenarios, potentially enhancing immunotherapy.
Area of Science:
- Oncology
- Radiation Oncology
- Dermatology
Background:
- Cutaneous malignant melanoma poses a global health challenge.
- Melanoma's historical radioresistance has limited radiation therapy (RT) use.
- Current RT indications include high-risk nodal disease and palliative care.
Purpose of the Study:
- To review the current applications of RT in melanoma management.
- To explore the expanding role of RT in oligometastatic melanoma.
- To highlight future potential of RT combined with immunomodulatory therapies.
Main Methods:
- Literature review of current and emerging RT applications in melanoma.
- Analysis of RT efficacy in various melanoma disease stages.
- Exploration of synergistic potential between RT and targeted immunotherapies.
Main Results:
- RT has limited use in primary melanoma but is valuable for nodal disease and palliation.
- RT is emerging as an alternative to surgery for oligometastatic melanoma.
- Combinatorial approaches with RT and immunotherapy show future promise.
Conclusions:
- RT's role in melanoma is expanding beyond traditional palliative and nodal indications.
- RT offers a viable alternative to surgery in select oligometastatic cases.
- Future research should focus on integrating RT with novel immunomodulatory treatments.
Related Concept Videos
Skin Cancer
6.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

